S
μg/ml for inhibiting synaptosomal serotonin uptake (consistent with doses of 900 mg extract
in humans). LD50 = >5000 mg/kg. Phototoxic reactions occur in some patients with AIDS
given ivn injections of 30–40 mg hypericin. “Not suitable for use as daily sedatives of sleep
aids. Preparations are no more effective than synthetic antidepressants,” but they are extremely
well tolerated by the patients. In observational studies or >3000 cases, there is ca. a 3% incidence
of minor side effects, cf 10–25% with modern nontricyclic antidepressants (SHT). In Germany,
the costs are about equal (tricyclics = 0.75 a day, hypericum 0.80 a day, cf $2.25 for nontricyclic
antidepressants (SHT).
STONECROP (Sedum acre L.) ++
Activities (Stonecrop) — Abortifacient (f; HHB); Diuretic (f; MAD); Emetic (f; HHB); Emmen-
agogue (f; MAD); Hypotensive (1; HHB); Laxative (f; HHB).
Indications (Stonecrop) — Adenopathy (f; JLH); Atherosclerosis (f; HHB; MAD); Bleeding
(f; HHB); Bright’s Disease (f; MAD); Bronchosis (f; MAD); Burn (f; HHB; PH2); Cancer (f;
MAD); Cancer, breast (f; JLH); Cancer, lymph (f; JLH); Cancer, nose (f; JLH); Cancer, skin
(f; MAD); Carcinoma (f; JLH); Cardiopathy (f; MAD); Catarrh (f; MAD); Condyloma (f;
JLH); Constipation (f; HHB) Corn (f; JLH); Cough (f; PH2); Dermatosis (f; FEL; MAD);
Diphtheria (f; HHB; MAD); Dropsy (f; MAD); Dysentery (f; HHB; MAD); Eczema (f; PH2);
Edema (f; MAD; PH2); Epilepsy (f; FEL; HHB; MAD); Fever (f; FEL; HH2); Hemorrhoid
(f; HHB; MAD); High Blood Pressure (1; HHB; MAD); Hypertony (f; HHB; MAD); Jaundice
(f; MAD); Lymphoma (f; JLH); Malaria (f; FEL; HHB); Mastosis (f; JLH); Nephrosis (f;
MAD); Pain (f; MAD); Pharyngosis (f; MAD); Proctosis (f; MAD); Prolapse (f; MAD);
Rhinosis (f; JLH); Scrofula (f; FEL); Sore (f; HHB; MAD); Sore Throat (f; HHB); Stomatosis
(f; HH2; PH2); Swelling (f; MAD); Wart (f; MAD; PH2); Water Retention (f; MAD); Whitlow
(f; JLH); Wound (1; MAD; PH2).
Dosages (Stonecrop) — 1 g powdered herb/day (MAD); 3 g/day (PH2); 1 tsp/cup water (PH2).
Contraindications, Interactions, and Side Effects (Stonecrop) — Not covered (AHP). “Hazards
and/or side effects not known for proper therapeutic dosages” (PH2). Not to be used in cases of
GI or urinary inflammation (PH2). LD50 of alkaloid mix 50 mg/kg ipr mus (HH2).
STONEROOT (Collinsonia canadensis L.) ++
Activities (Stoneroot) — Antilithic (f; PH2); Antioxidant (f; FAD); Antispasmodic (f; APA; HHB);
Astringent (1; APA; HHB); Carminative (1; HHB); Deodorant (f; DEM); Depurative (f; DEM);
Diaphoretic (f; APA; CAN); Diuretic (1; FAD; PHR; PH2); Emetic (1; APA; DEM; FAD); Litholytic
(f; CAN); Panacea (f; DEM); Sedative (f; APA); Stimulant (f; DEM); Stomachic (1; PHR; PH2);
Tonic (1; APA; PHR; PH2).
Indications (Stoneroot) — Backache (f; DEM); Bladder Stone (f; APA); Bleeding (f; DEM); Boil
(f; DEM); BPH (f; AKT); Bruise (f; FAD; HHB); Burn (f; FAD); Calculus (f; PHR; PH2); Cancer
(f; JLH); Cancer, tongue (f; JLH); Cardiopathy (f; DEM); Colic (f; DEM); Colitis (f; AKT);
Constipation (f; PH2); Cramp (f; APA; HHB); CVI (f; AKT); Cystosis (1; FAD; HHB; PH2);
Debility (f; DEM); Diarrhea (f; FAD; PH2); Dropsy (f; FAD; PHR); Dysentery (f; FAD); Dyspepsia
(f; FAD); Enterosis (1; PHR; PH2); Fever (f; APA; CAN); Gas (1; HHB); Gastrosis (1; AKT; PHR;
PH2); Glossosis (f; JLH); Headache (f; DEM); Hematochezia (f; DEM); Hemorrhoid (f; AKT;
APA; FAD; PH2); Inflammation (f; AKT; PH2); Insomnia (f; APA); Kidney Stone (f; APA);
Laryngosis (f; AKT; FAD); Leg Ache (f; DEM); Listlessness (f; DEM); Lithuria (f; PH2); Mastosis
(f; DEM); Nephrosis (f; CAN; FAD); Nervousness (f; APA); Pulmonosis (f; AKT); Rheumatism